XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Revenue $ 4,448 $ 10,379 $ 4,448 $ 10,379
Operating expenses:        
General and administrative (including stock-based compensation (Note 8)) 354,005 722,824 1,985,567 3,731,041
Depreciation 244,256 246,679 734,559 659,216
Research and development (including stock-based compensation (Note 8)) 79,190 53,259 25,745 139,578
Total operating expenses 677,451 1,022,762 2,745,871 4,529,835
Loss from operations (673,003) (1,012,383) (2,741,423) (4,519,456)
Interest expense 100,285 79,958 275,002 207,246
Other expense     1,918  
100,285 79,958 276,920 207,246
Net loss (773,288) (1,092,341) (3,018,343) (4,726,702)
Net loss attributable to the noncontrolling interest 1,327 1,466 4,065 4,257
Net loss attributable to Bion (771,961) (1,090,875) (3,014,278) (4,722,445)
Dividends on preferred stock (500) (1,000) (1,500) (3,917)
Net loss applicable to Bion's common stockholders $ (772,461) $ (1,091,875) $ (3,015,778) $ (4,726,362)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share) $ (0.04) $ (0.06) $ (0.16) $ (0.27)
Weighted-average number of common shares outstanding:        
Basic and diluted (in Shares) 18,783,957 17,476,779 18,412,042 17,197,996